On "The Final 5," former CDC Director Dr. Tom Frieden, author of the new book "The Formula for Better Health," urged viewers ...

Kimberly-Clark Corporation (NASDAQ: KMB) is one of the stocks Jim Cramer recently commented on. Cramer highlighted the ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

Personal healthcare products provider Kenvue Inc. (NYSE:KVUE) has been in the news for one reason or another recently.

A month after claiming a link between Tylenol use and autism, Health Secretary Robert F. Kennedy Jr. now says there's 'not ...

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?

Clark’s stock continued for a second day and raised the prospect that an activist investor could surface and try to block its ...

Kyle Kennedy was experiencing pain and swelling in his neck but doctors told him he had swollen glands and to take ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Hospitals across Baltimore are seeing an increase in patients but cannot point to a particular illness as the cause.

The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...